Aurora Investment Counsel Grows Position in Globe Life Inc. $GL

Aurora Investment Counsel increased its position in shares of Globe Life Inc. (NYSE:GL) by 2.7% during the second quarter, according to its most recent Form 13F filing with the SEC. The firm owned 15,615 shares of the company’s stock after buying an additional 405 shares during the period. Aurora Investment Counsel’s holdings in Globe Life were worth $1,941,000 at the end of the most recent reporting period.

A number of other large investors have also recently made changes to their positions in the company. AdvisorNet Financial Inc increased its stake in Globe Life by 60.0% in the second quarter. AdvisorNet Financial Inc now owns 224 shares of the company’s stock valued at $28,000 after purchasing an additional 84 shares during the last quarter. Amalgamated Bank increased its stake in Globe Life by 0.5% in the first quarter. Amalgamated Bank now owns 16,348 shares of the company’s stock valued at $2,153,000 after purchasing an additional 85 shares during the last quarter. Envestnet Portfolio Solutions Inc. increased its stake in Globe Life by 0.5% in the first quarter. Envestnet Portfolio Solutions Inc. now owns 19,776 shares of the company’s stock valued at $2,605,000 after purchasing an additional 89 shares during the last quarter. Venturi Wealth Management LLC increased its stake in Globe Life by 1.1% in the first quarter. Venturi Wealth Management LLC now owns 8,226 shares of the company’s stock valued at $1,084,000 after purchasing an additional 93 shares during the last quarter. Finally, HighPoint Advisor Group LLC increased its stake in Globe Life by 4.2% in the first quarter. HighPoint Advisor Group LLC now owns 2,366 shares of the company’s stock valued at $293,000 after purchasing an additional 95 shares during the last quarter. 81.61% of the stock is currently owned by hedge funds and other institutional investors.

Globe Life Stock Performance

Shares of GL opened at $135.29 on Tuesday. The company has a current ratio of 0.06, a quick ratio of 0.06 and a debt-to-equity ratio of 0.43. The firm has a market cap of $10.96 billion, a PE ratio of 10.81 and a beta of 0.55. The company’s 50 day simple moving average is $139.77 and its 200-day simple moving average is $129.09. Globe Life Inc. has a 12-month low of $100.27 and a 12-month high of $147.83.

Globe Life (NYSE:GL) last announced its earnings results on Wednesday, July 23rd. The company reported $3.27 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.25 by $0.02. The business had revenue of $1.48 billion for the quarter, compared to analyst estimates of $1.50 billion. Globe Life had a net margin of 18.11% and a return on equity of 21.24%. The company’s revenue for the quarter was up 2.9% compared to the same quarter last year. During the same period last year, the firm posted $2.97 earnings per share. Globe Life has set its FY 2025 guidance at 14.250-14.650 EPS. As a group, equities analysts predict that Globe Life Inc. will post 13.87 EPS for the current year.

Globe Life Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Friday, October 3rd will be issued a dividend of $0.27 per share. The ex-dividend date of this dividend is Friday, October 3rd. This represents a $1.08 annualized dividend and a dividend yield of 0.8%. Globe Life’s dividend payout ratio (DPR) is currently 8.63%.

Insider Buying and Selling

In related news, CEO Frank M. Svoboda sold 12,500 shares of the stock in a transaction on Thursday, July 31st. The stock was sold at an average price of $141.38, for a total transaction of $1,767,250.00. Following the completion of the sale, the chief executive officer directly owned 32,747 shares of the company’s stock, valued at $4,629,770.86. This trade represents a 27.63% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CFO Thomas Peter Kalmbach sold 28,952 shares of the stock in a transaction on Tuesday, July 29th. The stock was sold at an average price of $140.97, for a total value of $4,081,363.44. Following the sale, the chief financial officer directly owned 30,665 shares of the company’s stock, valued at approximately $4,322,845.05. This represents a 48.56% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 84,722 shares of company stock valued at $11,733,793 in the last ninety days. Company insiders own 1.97% of the company’s stock.

Analyst Ratings Changes

Several equities analysts have commented on GL shares. Weiss Ratings reiterated a “buy (b-)” rating on shares of Globe Life in a research note on Wednesday, October 8th. Cfra Research upgraded shares of Globe Life to a “moderate buy” rating in a research note on Friday, July 25th. JPMorgan Chase & Co. increased their price target on shares of Globe Life from $145.00 to $160.00 and gave the company an “overweight” rating in a research note on Tuesday, July 8th. Keefe, Bruyette & Woods increased their price target on shares of Globe Life from $145.00 to $155.00 and gave the company an “outperform” rating in a research note on Monday, July 28th. Finally, Wells Fargo & Company increased their price target on shares of Globe Life from $150.00 to $172.00 and gave the company an “overweight” rating in a research note on Wednesday, October 8th. Eight research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. Based on data from MarketBeat.com, Globe Life has an average rating of “Moderate Buy” and a consensus target price of $152.11.

Globe Life Company Profile

Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.